Physiologic evidence for the efficacy of positive expiratory pressure as an airway clearance technique in patients with cystic fibrosis.

BACKGROUND AND PURPOSE: Individuals with cystic fibrosis (CF) have large amounts of infected mucus in their lungs, which causes irreversible lung tissue damage. Although patient-administered positive expiratory pressure (PEP) breathing has been promoted as an effective therapeutic modality for remov...

Descripción completa

Detalles Bibliográficos
Publicado en:Physical Therapy Vol. 84; no. 6; pp. 524 - 538
Autores principales: Darbee JC, Ohtake PJ, Grant BJB, Cerny FJ
Formato: pictorial research tables/charts Journal Article
Publicado: Oxford University Press / USA Jun2004
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106774976&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106774976
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00319023
        PTH
      jtl: Physical Therapy
      issn: 00319023
      maglogo: N
    pubinfo:
      dt: Jun2004
      vid: 84
      iid: 6
      pid: 10398
      pub: Oxford University Press / USA
    artinfo:
      ui:
        106774976
        2004153633
        10.1093/ptj/84.6.524
        NLM15161418
        106774976
      ppf: 524
      ppct: 14
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Physiologic evidence for the efficacy of positive expiratory pressure as an airway clearance technique in patients with cystic fibrosis.
      aug:
        au:
          Darbee JC
          Ohtake PJ
          Grant BJB
          Cerny FJ
        affil: Assistant Professor, Department of Rehabilitation Sciences, Division of Physical Therapy, College of Health Sciences, University of Kentucky, 900 S. Limestone St., Lexington, KY 40536; darbee@uky.edu
      sug:
        subj:
          Cystic Fibrosis Therapy
          Positive End-Expiratory Pressure Methods
          Pulmonary Gas Exchange
          Positive End-Expiratory Pressure Equipment and Supplies
          Mucus
          Respiratory Function Tests
          Treatment Outcomes
          Vital Capacity
          Adolescence
          Adult
          Female
          Male
          Funding Source
          Human
          Adolescent: 13-18 years
          Adult: 19-44 years
          Female
          Male
      ab: BACKGROUND AND PURPOSE: Individuals with cystic fibrosis (CF) have large amounts of infected mucus in their lungs, which causes irreversible lung tissue damage. Although patient-administered positive expiratory pressure (PEP) breathing has been promoted as an effective therapeutic modality for removing mucus and improving ventilation distribution in these patients, the effects of PEP on ventilation distribution and gas mixing have not been documented. Therefore, this preliminary investigation described responses in distribution of ventilation and gas mixing to PEP breathing for patients with moderate to severe CF lung disease. SUBJECTS AND METHODS: The effects of PEP breathing on ventilation distribution, gas mixing, lung volumes, expiratory airflow, percentage of arterial blood oxyhemoglobin saturation (SpO(2)), and sputum volume were studied in 5 patients with CF (mean age=18 years, SD=4, range=13-22) after no-PEP, low-PEP (10-20 cm H(2)O), and high-PEP (>20 cm H(2)O) breathing conditions. Single-breath inert gas studies and lung function tests were performed before, immediately after, and 45 minutes after intervention. Single-breath tests assess ventilation distribution homogeneity and gas mixing by observing the extent to which an inspired test gas mixes with gas already residing in the lung. RESULTS: Improvements in gas mixing were observed in all PEP conditions. By 45 minutes after intervention, the no-PEP group improved by 5%, the low-PEP group improved by 15%, and the high-PEP group improved by 23%. Slow vital capacity increased by 1% for no PEP, by 9% for low PEP, and by 13% for high PEP 45 minutes after intervention. Residual volume decreased by 13% after no PEP, by 20% after low PEP, and by 30% after high PEP. Immediate improvements in forced expiratory flow during the middle half of the forced vital capacity maneuver (FEF(25%-75%)) were sustained following high PEP but not following low PEP. DISCUSSION AND CONCLUSION: This study demonstrated the physiologic basis for the efficacy of PEP therapy. The results confirm that low PEP and high PEP improve gas mixing in individuals with CF, and these improvements were associated with increased lung function, sputum expectoration, and SpO(2). The authors propose that improvements in gas mixing may lead to increases in oxygenation and thus functional exercise capacity.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N